{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:29:23Z","timestamp":1792132163712,"version":"4.4.0"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Diseases"],"abstract":"<jats:p>Psoriasis is a chronic, immune-mediated dermatosis that affects approximately 125 million people worldwide. Traditionally considered a dermatologic condition, it is now perceived as a systemic disease with numerous comorbidities. While its associations with psoriatic arthritis, metabolic syndrome, and psychiatric disorders are well established, less attention has been given to its coexistence with other dermatoses. This narrative review aims to explore and summarize the existing evidence on the relationships between psoriasis and other skin diseases, highlighting potential overlaps in clinical presentation, pathogenesis, and treatment challenges. Psoriasis may coexist with several inflammatory and autoimmune skin disorders, including atopic dermatitis, lichen simplex chronicus, anti-p200 pemphigoid, pityriasis rubra pilaris, seborrheic dermatitis, inflammatory linear verrucous nevus (ILVEN), Sneddon\u2013Wilkinson disease, and vitiligo. The review highlights the shared genetic pathways (e.g., the Th1\/Th17 axis and IL-17 pathway), diagnostic challenges (e.g., sebopsoriasis and psoriasis\u2013eczema overlap), and therapeutic considerations (e.g., paradoxical reactions to biologics and effectiveness of JAK inhibitors in both psoriasis and vitiligo). The coexistence of psoriasis with other dermatoses is more common and clinically significant than previously appreciated. Recognizing these associations is crucial for an accurate diagnosis, avoiding mismanagement, and optimizing individualized treatment strategies. Further research is needed to elucidate the underlying mechanisms and improve the multidisciplinary care for patients with complex dermatologic presentations.<\/jats:p>","DOI":"10.3390\/diseases13100322","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:58:13Z","timestamp":1759305493000},"page":"322","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psoriasis in the Context of Dermatologic Disorders: A Comprehensive Overview"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-1167","authenticated-orcid":false,"given":"Julia","family":"Nowowiejska-Purpurowicz","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 14 Zurawia St, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Lemiesz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 14 Zurawia St, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-910X","authenticated-orcid":false,"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 14 Zurawia St, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tsai, Y.C., and Tsai, T.F. (2022). Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105518"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic Dermatitis","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000530608","article-title":"Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review","volume":"239","author":"Su","year":"2023","journal-title":"Dermatology"},{"key":"ref_7","unstructured":"Charifa, A., Badri, T., and Harris, B.W. (2025, June 01). Lichen Simplex Chronicus, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499991\/."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Xie, Y.H., Wang, S.H., Li, S.Z., and Zuo, Y.G. (2022). Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.839094"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40257-017-0338-1","article-title":"A Review on Pityriasis Rubra Pilaris","volume":"19","author":"Wang","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e151911","DOI":"10.1172\/jci.insight.151911","article-title":"Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris","volume":"6","author":"Shao","year":"2021","journal-title":"JCI Insight"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ced.14625","article-title":"Erythroderma (exfoliative dermatitis). Part 1: Underlying causes, clinical presentation and pathogenesis","volume":"46","author":"Tso","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2018.03.036","article-title":"Biologics for pityriasis rubra pilaris treatment: A review of the literature","volume":"79","author":"Napolitano","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.21708","article-title":"Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: A single-arm clinical trial with transcriptomic analysis","volume":"187","author":"Boudreaux","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_15","unstructured":"(2025, September 22). The clinical trials register: ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/search?cond=Pityriasis%20Rubra%20Pilaris."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/exd.14091","article-title":"An Update on the Microbiology, Immunology and Genetics of Seborrheic Dermatitis","volume":"29","author":"Adalsteinsson","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of seborrheic dermatitis: A comprehensive review","volume":"30","author":"Borda","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jdv.17354","article-title":"Clinical and trichoscopic features in various forms of scalp psoriasis","volume":"35","author":"Bruni","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.023","article-title":"Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and \u03b2-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor \u03b1 inhibitor-associated dermatitis","volume":"82","author":"Cohen","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/pde.15094","article-title":"Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders","volume":"39","author":"Atzmony","year":"2022","journal-title":"Pediatr. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2340\/00015555-0522","article-title":"ILVEN: Is it psoriasis? Debate based on successful treatment with etanercept","volume":"88","author":"Renner","year":"2008","journal-title":"Acta Derm. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/0019-5154.103072","article-title":"Naevoid Psoriasis and ILVEN: Same Coin, Two Faces?","volume":"57","author":"Sengupta","year":"2012","journal-title":"Indian. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000090647","article-title":"Linear psoriasis and ILVEN: Is. lumping or splitting appropriate?","volume":"212","author":"Happle","year":"2006","journal-title":"Dermatology"},{"key":"ref_24","first-page":"216","article-title":"Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis","volume":"14","author":"Vissers","year":"2004","journal-title":"Eur. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdcr.2024.12.031","article-title":"Inflammatory linear verrucous epidermal nevus successfully treated with ustekinumab","volume":"58","author":"Almarzooqi","year":"2025","journal-title":"JAAD Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000090648","article-title":"Does Inflammatory Linear Verrucous Epidermal Nevus Represent a Segmental Type 1\/Type 2 Mosaic of Psoriasis?","volume":"212","author":"Hofer","year":"2006","journal-title":"Dermatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","article-title":"\u201cAutoinflammatory psoriasis\u201d-genetics and biology of pustular psoriasis","volume":"18","author":"Uppala","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/PTT.S400402","article-title":"Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies","volume":"13","author":"Heidemeyer","year":"2023","journal-title":"Psoriasis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/24755303251318976","article-title":"Management of Chronic Generalized Pustular Psoriasis: A Review and Expert Opinion","volume":"10","author":"Elewski","year":"2025","journal-title":"J. Psoriasis Psoriatic Arthritis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"T801","DOI":"10.1016\/j.ad.2024.07.012","article-title":"[Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts","volume":"115","year":"2024","journal-title":"Actas Dermosifiliogr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijwd.2020.02.003","article-title":"Subcorneal pustular dermatosis: Comprehensive review and report of a case presenting during pregnancy","volume":"6","author":"Bhargava","year":"2020","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e15552","DOI":"10.1111\/dth.15552","article-title":"Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab","volume":"35","author":"Romagnuolo","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5114\/dr.2020.93972","article-title":"Subcorneal pustular dermatosis successfully treated with acitretin","volume":"107","author":"Jaworek","year":"2020","journal-title":"Dermatol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5603\/FD.2020.0015","article-title":"Subcorneal Pustular Dermatosis associated with psoriasis vulgaris\u2014acitretin treatment","volume":"6","author":"Mehrholz","year":"2020","journal-title":"Forum Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","article-title":"Dapsone in dermatology and beyond","volume":"306","author":"Wozel","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.2340\/actadv.v105.44512","article-title":"Successful Treatment of Subcorneal Pustular Dermatosis with Abrocitinib","volume":"105","author":"Chen","year":"2025","journal-title":"Acta Derm. Venereol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: A Review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","article-title":"Association Between Psoriasis and Vitiligo: A Systematic Review and Meta-Analysis","volume":"20","author":"Yen","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/JD9.0000000000000337","article-title":"Identification of Key Pathways and Genes Involved in Psoriasis and Vitiligo Using Bioinformatics Analysis","volume":"8","author":"Zhang","year":"2025","journal-title":"Int. J. Dermatol. Venereol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2249.2002.01949.x","article-title":"Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA\/MART1","volume":"129","author":"Waterman","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40291-023-00646-1","article-title":"Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights","volume":"27","author":"Abdallah","year":"2023","journal-title":"Mol. Diagn. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Shi, X., Yuan, Y., Sun, R., Zhu, M., Du, J., Wang, F., and Ding, X. (2025). Real world effectiveness and safety of oral Janus kinase inhibitor in vitiligo: A retrospective study. J. Am. Acad. Dermatol.","DOI":"10.1016\/j.jaad.2025.09.055"},{"key":"ref_43","unstructured":"The Drugs.com database (2025, September 22). Opzelura FDA Approval History. Available online: https:\/\/www.drugs.com\/history\/opzelura.html."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/ijd.17594","article-title":"Reply to: Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: A case series","volume":"64","author":"Foggia","year":"2025","journal-title":"Int. J. Dermatol."},{"key":"ref_45","unstructured":"The Drugs.com database (2025, September 22). Rinvoq FDA Approval History. Available online: https:\/\/www.drugs.com\/history\/rinvoq.html."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/10\/322\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:25:04Z","timestamp":1759465504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/10\/322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["diseases13100322"],"URL":"https:\/\/doi.org\/10.3390\/diseases13100322","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}